Exact Sciences
EXAS
#1715
Rank
S$13.34 B
Marketcap
$72.11
Share price
0.75%
Change (1 day)
-17.25%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.13

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.14. In 2022 the company made an earnings per share (EPS) of -$4.77 a decrease over its 2021 EPS that were of -$4.67.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-55.44%
2022-$4.772.31%
2021-$4.67-37.09%
2020-$7.42674.65%
2019-$0.96-50.69%
2018-$1.9444%
2017-$1.35-39.39%
2016-$2.23-2.94%
2015-$2.2937.1%
2014-$1.6779.71%
2013-$0.93-21.59%
2012-$1.1962.96%
2011-$0.7392.86%
2010-$0.38-3.45%
2009-$0.39-19.44%
2008-$0.49-18.18%
2007-$0.59-10.2%
2006-$0.66-10.91%
2005-$0.74-24.66%
2004-$0.98-51.33%
2003-$2.02-7.41%
2002-$2.1811.72%
2001-$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.10 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.46-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.54-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$68.64 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.29-300.57%๐Ÿ‡ซ๐Ÿ‡ท France